AI investment and geopolitics are reshaping global equity markets, driving volatility and increasing dispersion across regions, sectors, and factors. In this environment, investors should consider balancing selective exposure to structural growth opportunities against geopolitical headwinds, while maintaining diversification.
Within developed markets, the US appears well-positioned to capitalise on AI-led growth. The AI investment cycle may provide a growth impulse for the broader US economy, and the focus is likely to gradually expand from AI infrastructure providers and technology enablers to a broader range of companies benefiting from enhanced productivity.
Geopolitical tensions and ongoing deglobalisation are encouraging a reshoring of US capital investment, with greater focus on building domestic manufacturing capabilities and supply chains. The US economy is also relatively insulated from geopolitically driven commodity shocks.
This combination of AI leadership, a renewed investment cycle, and geopolitical resilience is evident in the US macro backdrop, with 2026 GDP growth expected to reach 2.1%, compared with 0.6% in both Japan and the Eurozone.1 Manufacturing surveys tell a similar story: the S&P Global US Manufacturing Purchasing Managers’ Index (PMI) stood at 53.9 in June, versus 51.4 for the Eurozone equivalent.2 The US labour market remains stable, with unemployment at 4.2% in June.3
Equity market performance rarely moves in lockstep with economic data, but this underlying resilience may provide a supportive backdrop for earnings growth and reinforces the case for allocating risk towards a region that has demonstrated relative strength.
The unevenness of economic growth within the developed world may prompt investors to favour US exposures with a domestic tilt, as US gross private domestic investment is expected to grow by 3.6% to 3.9% per year from 2026 to 2028.4
Against this backdrop, US small- and mid-cap equities may offer a more direct way to access domestic strength, as they derive a larger share of revenue from the US economy than their large-cap counterparts. As a result, they may be well placed to benefit from a resilient economic backdrop and an expanding investment cycle.
The Russell 2000 Index and the S&P MidCap 400 Index have outperformed the S&P 500 by 12 and 7 percentage points year to date, respectively, despite an environment of rising yields.5
Small- and mid-caps have so far absorbed rising yields, as a robust US economy provides room for revenue expansion. This is reflected in 2026 earnings growth forecasts of 48% for the Russell 2000 and 22% for the S&P MidCap 400.6
In addition, mid-caps trade at less demanding price-to-earnings (P/E) multiples than large caps, offering a combination of lower valuations and robust earnings growth potential. The valuation picture of US small caps is more nuanced, as a significant share of constituents is not currently profitable. However, viewed in a 10-year context (Figure 3), small-cap multiples on this basis remain well below those of large caps.
Valuation multiples have played a relatively limited role in driving markets since the pandemic, but in 2026 investors have so far placed greater emphasis on P/E levels. In the first two months of the year, US small-cap stocks and cyclical sectors such as Materials and Industrials outperformed US Technology stocks, reflecting concerns over the latter’s elevated P/E multiples.
That trend reversed in the second quarter. By then, however, technology valuation multiples had compressed due to relatively weak performance and upward revisions to earnings estimates, setting up the subsequent rally in Technology stocks.7 Market moves in the first half of the year suggest that investors have been seeking value opportunities within sectors, rather than limiting their focus to traditionally discounted segments of the market.
Investors seeking value exposure without reducing their allocation to fast-growing sectors, such as Technology, may consider the sector-neutral MSCI USA Value Exposure Select Index. The index gained 25% in the first half of 2026, outperforming the MSCI USA Index and the standard MSCI USA Value Index by 15.6 and 15.1 percentage points, respectively.8
Meanwhile, the index’s forward P/E ratio remains attractive at 11.1x, compared with 20.7x for the MSCI USA Index,9 while the index maintains an Information Technology allocation of 38%, broadly in line with the parent benchmark.10 In addition, the MSCI USA Value Exposure Select Index incorporates a modest quality overlay, helping to filter out companies that may be “cheap for a reason”.
The MSCI USA Value Exposure Select Index may be the preferred option for investors expecting a higher rate environment, while small caps, which have so far absorbed modest yield rises, may offer greater potential upside if inflation pressures moderate. For investors seeking both exposures, the MSCI USA Small Cap Value Weighted Index blends domestically-oriented, cyclical small-cap exposure with a strong value tilt.
Equity indexes remain heavily concentrated, a potential source of market fragility. The top 10 constituents account for 36% of the S&P 500 Index, while the US represents 72% of the MSCI World Index.11 Although the outlook for US markets remains constructive, diversification remains a prudent consideration for investors.
However, developed markets outside the US, including Europe and Japan, present subdued growth prospects, and equity valuations in those regions do not appear compelling alongside relatively moderate earnings growth expectations.12
Emerging market equities, in contrast, offer potential diversification benefits and combine stronger growth prospects with relatively attractive valuations. The MSCI EM Index is heavily weighted towards EM Asia, which accounts for 84% of the benchmark,13 providing an effective counterweight to a US-dominated global equity allocation. EM Asia also offers one of the most direct routes into the AI theme.
Sustained demand for semiconductors has fuelled earnings growth across emerging markets, which is expected to reach nearly 50% in 2026.14 This demand shows few signs of moderating, and emerging markets earnings growth is expected to remain strong into 2027, albeit at a slower pace (see Figure 5).
Figure 5: Forecasted EPS growth and valuation multiples
Taiwan and South Korea, which account for 27% and 24% of the MSCI EM Index, respectively, and are global leaders in the semiconductor and hardware industries,15 are driving much of this earnings growth. Over the longer term, however, the EM growth story extends well beyond AI.
Emerging markets remain a key driver of global economic expansion, with growth rates generally exceeding those of developed markets. India stands out as a structural growth leader, while China, despite its economic slowdown, continues to expand at a faster pace than most developed economies, including the US.
Broader structural trends underpin EM growth. Favourable demographics in markets such as India, urbanization, and rising consumer spending all support growth. Companies in Latin America and the Middle East provide additional diversification through their exposure to commodity-related sectors.
This diverse set of growth drivers, from technology and manufacturing to consumption, reinforces EM’s potential as a strong portfolio diversifier. It provides exposure to faster-growing economies at a time when developed market growth remains, with the exception of the US, relatively constrained.
EM’s large- and mid-cap companies may help reduce US large-cap concentration risk, but the MSCI EM Index is itself concentrated. The top 10 constituents represent 40% of the benchmark,16 and, in the short term, the exposure remains sensitive to AI-related dynamics. Against this backdrop, EM small-cap equities may offer a differentiated and diversified way to access the emerging markets growth story. The top 10 companies account for less than 7% of the MSCI EM Small Cap Index.17
While EM small caps retain exposure to technology and innovation, they are less reliant on the largest semiconductor and internet companies, providing more balanced access to local consumption trends and domestic economic activity. With an overweight allocation to India, and only a 9% allocation to China, they combine growth potential with diversification benefits.
Implementation Ideas:
Europe appears less well-positioned than the US to benefit from AI-driven growth, and its dependence on imported resources leaves it more exposed to geopolitical fragmentation, weighing on structural growth prospects. Any durable easing of Middle East tensions may provide near-term support for European equities through lower energy costs and valuation re-rating, but the region continues to face longer-term constraints on earnings growth.
The same geopolitical headwind, however, creates selective opportunities within European equities. The threat from Russia, longer-term instability in the Middle East and increased pressure from the United States for European countries to strengthen their defence capabilities are supporting a multi-year increase in defence spending. Governments across the region have already raised military budgets and expected to progress towards their stated spending commitments.
Initiatives such as ReArm Europe, including the Security Action for Europe (SAFE) financing programme, fiscal flexibility and reallocation of EU funds, are all likely to benefit European defence and defence-adjacent companies. Policymakers increasingly view local manufacturing not only as an economic objective but also as a strategic necessity, reflecting the need for greater self-sufficiency in an increasingly fragmented geopolitical environment.
While traditional military equipment and munitions remain central to spending plans, investment is also likely to extend to cyber security, communications infrastructure, drones, and advanced defence technologies.Beyond defence, higher fiscal spending, particularly in Germany, could support infrastructure development and create a long-term tailwind for industrial companies, even as other cyclical sectors in Europe appear less compelling.
In this context, the European defence and broader industrials sectors represent growth opportunities within an otherwise low-growth European equity market. The recent underperformance of defence companies appears to reflect short-term factors such as elevated valuations after the 2025 rally and idiosyncratic, contract-specific developments such as Germany’s decision to cancel the F126 frigate programme, rather than a deterioration in the long-term investment case. With the sector’s structural growth drivers intact, the pullback may present an opportunity for long-term investors.
For investors cautious about the European growth outlook, European Health Care may offer a defensive alternative. The sector provides access to established, non-cyclical businesses, yet trades at a 4% P/E premium to the broader market, compared with its 10-year average of approximately 17%.18
The Europe Health Care sector includes several global industry leaders, and constituents of the MSCI Europe Health Care Index generate approximately 71% of their revenues outside Europe.19 As a result, their earnings are less reliant on the relatively slow European economy. The sector may also stand to benefit from AI adoption, particularly in drug discovery, clinical trial optimisation and manufacturing efficiency.
Individual pharmaceutical and biotechnology companies often face company-specific risks, including research and development outcomes, patent expirations, product concentration, and litigation. A broad sector ETF exposure can help diversify these idiosyncratic risks while maintaining access to the sector's structural growth drivers.
Implementation Ideas:
Marketing Communication
Information Classification: General Access
For Professional Clients Only
For Investors in Switzerland: The collective investment schemes referred to herein are collective investment schemes under Irish law. Prospective investors may obtain the current sales prospectus, the articles of incorporation, the KID as well as the latest annual and semi-annual reports free of charge from the Swiss Representative and Paying Agent, State Street Bank International GmbH, Munich, Zurich Branch, Kalanderplatz 5, 8045 Zürich, as well as from the main distributor in Switzerland, State Street Global Advisors AG, Kalanderplatz 5, 8045 Zürich. Before investing please read the prospectus and the KID, copies of which can be obtained from the Swiss representative, or at www.ssga.com.
Issuer Entity
For Investors in the EU: This document has been issued by State Street Global Advisors Europe Limited (“SSGAEL”), regulated by the Central Bank of Ireland. Registered office address 78 Sir John Rogerson’s Quay, Dublin 2. Registered number 49934. T: +353 (0)1 776 3000. F: +353 (0)1 776 3300. Web: ssga.com.
For Investors in the UK: This document has been issued by State Street Global Advisors Limited (“SSGAL”). Authorized and regulated by the Financial Conduct Authority, Registered No.2509928. VAT No. 5776591 81. Registered office: 20 Churchill Place, Canary Wharf, London, E14 5HJ. Telephone: 020 3395 6000. Facsimile: 020 3395 6350 Web: www.ssga.com.
Currency Risk is a form of risk that arises from the change in price of one currency against another. Whenever investors or companies have assets or business operations across national borders, they face currency risk if their positions are not hedged.
ETFs trade like stocks, are subject to investment risk and will fluctuate in market value. The investment return and principal value of an investment will fluctuate in value, so that when shares are sold or redeemed, they may be worth more or less than when they were purchased. Although shares may be bought or sold on an exchange through any brokerage account, shares are not individually redeemable from the fund. Investors may acquire shares and tender them for redemption through the fund in large aggregations known as “creation units.” Please see the fund’s prospectus for more details.
SPDR ETFs is the exchange traded funds (“ETF”) platform of State Street Global Advisors and is comprised of funds that have been authorised by Central Bank of Ireland as open-ended UCITS investment companies.
State Street Global Advisors SPDR ETFs Europe I & SPDR ETFs Europe II plc issue SPDR ETFs, and is an open-ended investment company with variable capital having segregated liability between its sub-funds. The Company is organised as an Undertaking for Collective Investments in Transferable Securities (UCITS) under the laws of Ireland and authorised as a UCITS by the Central Bank of Ireland.
Investing involves risk including the risk of loss of principal.
Diversification does not ensure a profit or guarantee against loss.
The trademarks and service marks referenced herein are the property of their respective owners. Third party data providers make no warranties or representations of any kind relating to the accuracy, completeness or timeliness of the data and have no liability for damages of any kind relating to the use of such data.
The information provided does not constitute investment advice as such term is defined under the Markets in Financial Instruments Directive (2014/65/EU) or applicable Swiss regulation and it should not be relied on as such. It should not be considered a solicitation to buy or an offer to sell any investment. It does not take into account any investor’s or potential investor’s particular investment objectives, strategies, tax status, risk appetite or investment horizon. If you require investment advice you should consult your tax and financial or other professional advisor.
All information is from SSGA unless otherwise noted and has been obtained from sources believed to be reliable, but its accuracy is not guaranteed. There is no representation or warranty as to the current accuracy, reliability or completeness of, nor liability for, decisions based on such information and it should not be relied on as such.
The whole or any part of this work may not be reproduced, copied or transmitted or any of its contents disclosed to thirdparties without State Street Investment Management’s express written consent.
The views expressed in this material are the views of SPDR EMEA Strategy and Research through 30 June 2026 and are subject to change based on market and other conditions. This document contains certain statements that may be deemed forward-looking statements. Please note that any such statements are not guarantees of any future performance and actual results or developments may differ materially from those projected.
BLOOMBERG®, a trademark and service mark of Bloomberg Finance L.P., and its affiliates have each been licenced for use in connection with the listing and trading of the SPDR Bloomberg ETFs. SASB does not take any position as to whether an issuer should be included or excluded from the Underlying Index.
Investing in foreign domiciled securities may involve risk of capital loss from unfavourable fluctuation in currency values, withholding taxes, from differences in generally accepted accounting principles or from economic or political instability in other nations.
Investments in emerging or developing markets may be more volatile and less liquid than investing in developed markets and may involve exposure to economic structures that are generally less diverse and mature and to political systems which have less stability than those of more developed countries.
The Fund/share class may use financial derivatives instruments for currency hedging and to manage the portfolio efficiently. The Fund may purchase securities that are not denominated in the share class currency. Hedging should mitigate the impact of exchange rate fluctuations however hedges are sometimes subject to imperfect matching which could generate losses.
All the index performance results referred to are provided exclusively for comparison purposes only. It should not be assumed that they represent the performance of any particular investment.
The S&P 500® Index is a product of S&P Dow Jones Indices LLC or its affiliates (“S&P DJI”) and have been licensed for use by State Street Global Advisors. S&P®, SPDR®, S&P 500®,US 500 and the 500 are trademarks of Standard & Poor’s Financial Services LLC (“S&P”); Dow Jones® is a registered trademark of Dow Jones Trademark Holdings LLC (“Dow Jones”) and has been licensed for use by S&P Dow Jones Indices; and these trademarks have been licensed for use by S&P DJI and sublicensed for certain purposes by State Street Global Advisors. The fund is not sponsored, endorsed, sold or promoted by S&P DJI, Dow Jones, S&P, their respective affiliates, and none of such parties make any representation regarding the advisability of investing in such product(s) nor do they have any liability for any errors, omissions, or interruptions of these indices.
Please refer to the Fund’s latest Key Information Document (KID)/Key Investor Information Document (KIID) and Prospectus before making any final investment decision. The latest English version of the prospectus and the KID/KIID can be found at ssga.com. A summary of investor rights can be found here: ssga.com/ library-content/products/fund-docs/summary-of-investor-rights/ ssga-spdr-investors-rights-summary.pdf.
Note that the Management Company may decide to terminate the arrangements made for marketing and proceed with de-notification in compliance with Article 93a of Directive 2009/65/EC.
The information contained in this communication is not a research recommendation or ‘investment research’ and is classified as a ‘Marketing Communication’ in accordance with the applicable regional regulation. This means that this marketing communication (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research (b) is not subject to any prohibition on dealing ahead of the dissemination of investment research.
The Fund/share class may use financial derivatives instruments for currency hedging and to manage the portfolio efficiently. The Fund may purchase securities that are not denominated in the share class currency. Hedging should mitigate the impact of exchange rate fluctuations however hedges are sometimes subject to imperfect matching which could generate losses.
9031383.1.2.EMEA.INST
EXP: 31 October 2026
© 2026 State Street Corporation - All Rights Reserved.